Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non–Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy-Reference-Cited by-全球学者库

Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non–Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy

Published:2021-08-01 Issue:8 Volume:7 Page:1178
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Hui Zhouguang¹,Men Yu¹,Hu Chen²,Kang Jingjing³⁴,Sun Xin³,Bi Nan³,Zhou Zongmei³,Liang Jun³,Lv Jima³,Feng Qinfu³,Xiao Zefen³,Chen Dongfu³,Wang Yan⁵,Li Junling⁵,Wang Jie⁵,Gao Shugeng⁶,Wang Luhua⁷,He Jie⁶

Affiliation:

1. Department of VIP Medical Services & Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

2. Division of Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland

3. Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

4. Department of Radiation Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China

5. Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

6. Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

7. Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing & Guangdong, China

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2781087/jamaoncology_hui_2021_oi_210026_1628879152.65728.pdf

Reference25 articles.

1. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials.;PORT Meta-analysis Trialists Group;Lancet,1998

2. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the Surveillance, Epidemiology, and End Results database.;Lally;J Clin Oncol,2006

3. Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution.;Dai;Oncologist,2011

4. Evidence supporting contemporary post-operative radiation therapy (PORT) using linear accelerators in N2 lung cancer.;Patel;Lung Cancer,2014

5. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.;Douillard;Lancet Oncol,2006

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant and neo-adjuvant therapy for non-small cell lung cancer without EGFR mutations or ALK rearrangements;International Journal of Clinical Oncology;2024-01-28

2. Postoperative radiotherapy improves disease-free survival of EGFR wild-type pN2 non-squamous- cell non-small-cell lung cancer (Nsq-NSCLC) patients after complete resection: a propensity score matching analysis;2024-01-15

3. Challenges to multimodal treatment of elderly patients with lung cancer;Die Onkologie;2024-01-02

4. Targeting PKD2 aggravates ferritinophagy-mediated ferroptosis via promoting autophagosome-lysosome fusion and enhances efficacy of carboplatin in lung adenocarcinoma;Chemico-Biological Interactions;2024-01

5. Treatment options for stage III-N2 pulmonary lymphoepithelioma-like carcinoma: A retrospective cohort study;Radiotherapy and Oncology;2023-12